Patients with rheumatoid arthritis increased their leg muscle volume when treated with an anti-rheumatic drug, offering new ...

South Korea's Hyundai ADM Bio said its new cancer drug under development, Penetrium, may prove effective treating diseases ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

Korean researchers found that low-dose radiation therapy eased knee pain and improved movement in people with mild to ...

Russian pharmaceutical company R-Pharm is working to retool rheumatoid arthritis drug, olokizumab, to treat COVID-19 patients with moderate to severe infections, its Chief Medical Officer Mikhail ...

Patients with PsA who are treated with CTT are not at a greater risk for serious or opportunistic infections compared with standard therapy.

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...

Treatment with guselkumab led to improvements in disease activity over 1 year among patients with PsA and showed a high retention rate.

The Food and Drug Administration has approved Enoby, a biosimilar to Prolia, and Xtrenbo, a biosimilar to Xgeva.

The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co's arthritis drug, baricitinib, in combination with Gilead Sciences Inc's remdesivir, to treat COVID-19 ...